Delivery Order SPE2DB24D8002-SPE2DB25FJNRU
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $3,331.66, is for the delivery of ondansetron odt 4 mg tablets in a 30-count package. The contract has a firm fixed price pricing type and a completion date of June 4, 2024. Dakota Drug, Inc. is a critical supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S....
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,958.24, is a firm-fixed-price delivery order for 4,567,087,425 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,481.81, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price arrangement with a completion date of May 9, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,644.01, is for the delivery of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a period of performance through February 3, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company...
This delivery order contract, valued at $1,993.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of 4,563,982 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with a performance period through March 18, 2024. This award is made as a firm fixed-price delivery order without any set-aside designation. Dakota Drug, Inc. has a long-standing history as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,528.14, is for the delivery of 4,564,170,794 units of the pharmaceutical product Ondansetron ODT 4 mg tablet in 30-count packages. This order, awarded on April 4, 2024, has a firm fixed-price structure and a completion date of April 5, 2024. Dakota Drug, Inc. specializes in supplying a wide range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,330.03, is a firm fixed-price delivery order for the supply of 4,565,166,563 units of the pharmaceutical product Ondansetron ODT 4 mg tablet. The contract has a period of performance ending on July 17, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of ondansetron ODT 4 mg tablets in 30-count packages, with a potential value of $1,689.06 and a completion date of January 8, 2024. The contract does not have a set-aside designation. As a prime contractor to the DLA Troop Support...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYXK, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,759.71, is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products,...
This federal contract award, identified as SPE2DX15D8002 and SPE2DX23F3AC4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,825.10, is for the delivery of 4562235187 Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of September 20, 2023. Dakota Drug, Inc. is an established federal...